Prescribers & Clinics
Cantourage Bets on Own Brand to Defend Flower Margins
Cantourage Group SE has announced the launch of its first proprietary medical cannabis brand for the German market, in a meaningful pivot for the distributor.
Cantourage
23stories
21 Jullast updated
More in Cantourage
- Markets & Stocks
Aurora & Demecan Launch First German-Grown Products, Stenocare Exits Cultivation Facility, & More From Cantourage
Stenocare Danish medical cannabis oil producer Stenocare has exited its cultivation facility in Denmark, just four years after it was completed.
- Markets & Stocks
High Tide Breaks into German Market, Cantourage Exceeds Projections in 2024, & More from SEED
Cantourage [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Berlin-based medical cannabis company Cantourage saw sales exceed its own projections in 2024, with sales more than doubling on 2023.
- Markets & Stocks
Cantourage Sees Record Profits, Akanda Announced Another Stock Split, & IMC Raises New Funding
Cantourage Group [stock_market_widget type=”chart” template=”line” assets=”HIGH.DE” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Cantourage has continued its run of positive financial results, reporting record profits for the third quarter and nearly doubling revenues year-on-year.
- Markets & Stocks
Voyager Life Offloads Cannabis Operations, Stenocare Drops Sales Guidance for a Second Time, & More from Cantourage
Voyager Life [stock_market_widget type=”chart” template=”line” assets=”VOY.AQ” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Voyager Life, which recently rebranded as Mendell Helium, has announced the sale of its cannabis-facing business after first announcing its intention to exit the space in June.
- Hemp Industry
Bedrocan Returns To Canada, Cantourage Sales To Hit €40m, EU Court Overturns Indoor Hemp Ban, Malta To Ease Cannabis Rec Restrictions
LONG-ESTABLISHED European cannabis company Bedrocan has re-entered the Canadian medical cannabis market following the purchase of a facility in Toronto.
- Markets & Stocks
Argent BioPharma Sees 74% Sales Decline, Cantourage Enjoys 62% Sales Increase, & Organigram Progresses With BAT Investment
Argent BioPharma [stock_market_widget type=”chart” template=”line” assets=”RGT.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June 30, 2024, revealing a sharp drop in revenues but a reigning in of net losses compared to the previous year.
- Markets & Stocks
Cantourage & Celadon Announce Double Digit Growth in 2023, Hellenic Dynamics Announces Further Fundraise
Celadon Pharmaceuticals [stock_market_widget type=”chart” template=”line” assets=”CEL.L” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] Celadon Pharmaceuticals this week released its full-year results for 2023, reporting revenues over three times those seen in 2022.
- Markets & Stocks
CanG’s Passage Drives Up Global Cannabis Stock Prices, & Jazz Pharma Pays $7.5m To Settle Lawsuit Over GW Acquisition
Germany’s passage of CanG continues to drive up stock prices Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany’s landmark CanG bill, meaning it is now all but certain to be brought into law on April 01.
